Petroleo Brasileiro SA Petrobras
PBR
Vale SA
VALE
Ecopetrol
EC
4
Taylor Morrison Home
TMHC
5
KB Home
KBH
US Stock MarketDetailed Quotes
LEGN Legend Biotech
- 35.060
- -0.330-0.93%
Close Mar 28 16:00 ET
- 35.060
- 0.0000.00%
Post 20:01 ET
6.44BMarket Cap-36.52P/E (TTM)
35.740High34.590Low504.81KVolume35.110Open35.390Pre Close17.69MTurnover0.62%Turnover RatioLossP/E (Static)183.65MShares60.87052wk High6.19P/B2.84BFloat Cap30.17052wk Low--Dividend TTM81.13MShs Float77.320Historical High--Div YieldTTM3.25%Amplitude23.410Historical Low35.039Avg Price1Lot Size
Legend Biotech Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 119.97%627.24M | 134.73%186.52M | 66.86%160.21M | 154.36%186.52M | 158.67%93.99M | 143.70%285.14M | 187.57%79.46M | 250.91%96.01M | 512.56%73.33M | -27.39%36.34M |
| Operating revenue | 117.92%620.98M | 134.56%186.3M | 66.60%159.92M | 151.27%184.1M | 149.90%90.66M | 144.23%284.96M | 189.43%79.42M | 251.64%95.99M | 513.78%73.27M | -27.44%36.28M |
| Cost of revenue | 62.66%234.58M | 127.80%73.92M | 27.58%55.47M | 54.42%50.45M | 53.71%54.74M | 120.64%144.21M | 41.31%32.45M | 70.77%43.48M | 92.88%32.67M | 35.61M |
| Gross profit | 178.62%392.66M | 139.50%112.6M | 99.37%104.74M | 234.67%136.07M | 5,329.05%39.25M | 172.90%140.93M | 906.94%47.01M | 2,663.49%52.53M | 918.40%40.66M | -98.56%723K |
| Operating expense | 19.90%695.9M | 12.06%187M | 20.64%174.79M | 23.07%177.62M | 25.87%156.5M | 14.42%580.41M | 26.52%166.86M | -1.09%144.88M | 26.26%144.33M | 7.65%124.34M |
| Selling and administrative expenses | 41.48%284.26M | 33.25%83.13M | 61.72%79.57M | 33.01%65.42M | 39.82%56.15M | 15.44%200.93M | 18.82%62.38M | 16.88%49.2M | 8.12%49.18M | 18.26%40.16M |
| -Selling and marketing expense | 56.63%147.48M | 45.28%48.93M | 109.83%44.27M | 40.29%30.06M | 34.92%24.22M | 0.79%94.16M | 30.41%33.68M | 11.91%21.1M | -21.91%21.43M | -15.72%17.95M |
| -General and administrative expense | 28.11%136.78M | 19.14%34.2M | 25.60%35.3M | 27.38%35.35M | 43.79%31.93M | 32.42%106.77M | 7.59%28.71M | 20.91%28.1M | 53.76%27.75M | 75.44%22.21M |
| Research and development costs | 8.20%413.54M | -1.18%104.43M | -0.35%95.52M | 17.57%112.63M | 18.94%100.96M | 13.87%382.22M | 30.87%105.68M | -8.29%95.86M | 39.18%95.79M | 4.10%84.89M |
| Other operating expenses | 30.25%-1.91M | 53.20%-563K | -73.86%-306K | 34.58%-420K | 13.24%-616K | -12.20%-2.73M | 12.06%-1.2M | -30.37%-176K | ---642K | ---710K |
| Operating profit | 31.00%-303.24M | 37.93%-74.4M | 24.14%-70.05M | 59.92%-41.55M | 5.15%-117.25M | 3.54%-439.49M | 5.80%-119.85M | 36.13%-92.35M | 13.09%-103.67M | -88.82%-123.62M |
| Net non-operating interest income expense | 21.09%39.59M | -25.95%8.5M | -12.69%11.13M | 69.45%11.57M | 411.27%8.4M | 1,350.69%32.69M | 40,907.14%11.48M | 831.99%12.74M | 515.40%6.83M | 257.28%1.64M |
| Non-operating interest income | 12.33%61.2M | -21.08%13.65M | -9.71%16.63M | 41.96%17.05M | 105.33%13.87M | 565.94%54.49M | 253.90%17.3M | 1,122.30%18.42M | --12.01M | --6.76M |
| Non-operating interest expense | -0.82%21.62M | -11.48%5.15M | -3.03%5.5M | 5.77%5.48M | 7.08%5.48M | 101.87%21.79M | 19.73%5.82M | 74.75%5.68M | 215.58%5.19M | 389.75%5.11M |
| Other net income (expense) | 193.11%105.52M | 376.78%106.4M | -462.19%-61.96M | 111.78%12.02M | 390.65%49.07M | -1,005.88%-113.33M | -350.80%-38.44M | -72.19%17.11M | -41.37%-101.99M | -70.92%10M |
| Gain on sale of security | 228.51%109.35M | ---- | ---- | 110.79%11.4M | 139.10%49.51M | -495.70%-85.09M | -18.03%-10.27M | -83.38%10.17M | -60.39%-105.7M | -40.67%20.71M |
| Special income (charges) | ---4.42M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Write off | --4.42M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Other non- operating income (expenses) | 102.12%598K | 105.26%1.48M | -115.25%-1.06M | -83.42%615K | 95.89%-440K | -214.01%-28.24M | -16,773.96%-28.18M | 2,115.97%6.94M | 159.41%3.71M | -1,978.64%-10.71M |
| Income before tax | 69.60%-158.13M | 127.59%40.51M | -93.43%-120.89M | 90.96%-17.97M | 46.60%-59.79M | -16.69%-520.12M | -8.17%-146.81M | 26.31%-62.5M | -2.99%-198.84M | -248.54%-111.97M |
| Income tax | 1,113.57%18.89M | 813.49%14.23M | 1,639.93%4.44M | -22.07%226K | -96.09%5K | -398.24%-1.86M | -1,403.27%-1.99M | -289.47%-288K | 84.71%290K | -21.47%128K |
| Net income | 65.84%-177.03M | 118.15%26.28M | -101.46%-125.32M | 90.86%-18.2M | 46.66%-59.79M | -16.11%-518.25M | -6.58%-144.82M | 26.78%-62.21M | -3.05%-199.13M | -247.18%-112.1M |
| Net income continuous Operations | 65.84%-177.03M | 118.15%26.28M | -101.46%-125.32M | 90.86%-18.2M | 46.66%-59.79M | -16.11%-518.25M | -6.58%-144.82M | 26.78%-62.21M | -3.05%-199.13M | -247.18%-112.1M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 65.84%-177.03M | 118.15%26.28M | -101.46%-125.32M | 90.86%-18.2M | 46.66%-59.79M | -16.11%-518.25M | -6.58%-144.82M | 26.78%-62.21M | -3.05%-199.13M | -247.18%-112.1M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 65.84%-177.03M | 118.15%26.28M | -101.46%-125.32M | 90.86%-18.2M | 46.66%-59.79M | -16.11%-518.25M | -6.58%-144.82M | 26.78%-62.21M | -3.05%-199.13M | -247.18%-112.1M |
| Basic earnings per share | 67.35%-0.96 | 117.50%0.14 | -118.75%-0.7 | 91.23%-0.1 | 52.94%-0.32 | -5.00%-2.94 | 2.44%-0.8 | 38.46%-0.32 | 8.06%-1.14 | -240.00%-0.68 |
| Diluted earnings per share | 67.35%-0.96 | 117.50%0.14 | -118.75%-0.7 | 91.23%-0.1 | 52.94%-0.32 | -5.00%-2.94 | 2.44%-0.8 | 38.46%-0.32 | 8.06%-1.14 | -240.00%-0.68 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025